Nicolas Desbenoit

Nicolas Desbenoit

Auto-generated profile, based on publicly available information

Nicolas Desbenoit

Univ. Bordeaux, CNRS, CBMN

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 November 2020 in Analytical Chemistry
Verified
Journal Article
Closed access
MTMichael Tuck
Michael Tuck
LBLandry Blanc
Landry Blanc
RTRita Touti
Rita Touti
NPNathan Heath Patterson
Nathan Heath Patterson
SNSebastiaan Van Nuffel
Sebastiaan Van Nuffel
NDNicolas Desbenoit
Nicolas Desbenoit

3 December 2021 in Analytical Chemistry
Verified
Journal Article
Closed access
LBLandry Blanc
Landry Blanc
GFGino B. Ferraro
Gino B. Ferraro
MTMichael Tuck
Michael Tuck
BPBrendan Prideaux
Brendan Prideaux
VDVeronique A Dartois
Veronique A Dartois
NDNicolas Desbenoit
Nicolas Desbenoit

23 March 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
LBLandry Blanc
Landry Blanc
FGFlorent Grelard
Florent Grelard
MTMichael Tuck
Michael Tuck
VDVeronique A Dartois
Veronique A Dartois
APAntonio Peixoto
Antonio Peixoto
NDNicolas Desbenoit
Nicolas Desbenoit
In this work, we introduce a multimodal imaging workflow that integrates Matrix-assisted Laser Desorption Ionization Mass Spectrometry Imaging (MALDI-MSI) combined with Immunofluorescence (IF) microscopy to enhance in tissue spatial single-cell metabolomics. The workflow allows to correlate cell populations with associated small molecule distributions by conducting on the same tissue section MSI before IF staining, addressing tissue integrity challenges and joint image analysis. To process MSI data with IF guidance, we propose an original and advanced computational strategy utilizing Receiver Operating Characteristic (ROC) analysis, allowing to identify ions specific to targeted histological regions based on IF staining. Moreover, in a non-targeted strategy, we introduce a Spatial Coherence Measure (SCM) to distinguish genuine spatial patterns from noise within ion distributions, enhancing spatial metabolomics’ robustness. Then spatial clustering techniques are employed to group ions sharing similar spatial distribution to reveal histological structures, providing complementary insights into metabolite distributions. We validated our workflow mouse spleen section as this organ presents a spatially complex but well-detailed microenvironment. In conclusion, our multimodal and computational workflow opens new frontiers for diverse biomedical research applications by promoting precise spatial metabolomics in tissue sections.

2 December 2023
Verified
Book Chapter
Closed access
PDF file
FGFlorent Grélard
Florent Grélard
MTMichael Tuck
Michael Tuck
ECElise Cosenza
Elise Cosenza
DLDavid Legland
David Legland
MDMarléne Durand
Marléne Durand
NDNicolas Desbenoit
Nicolas Desbenoit

22 October 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
JGJohanna Galvis
Johanna Galvis
MMMélanie Moreau
Mélanie Moreau
SLSébastian Lillo
Sébastian Lillo
DBDoriane Bomont
Doriane Bomont
LLLéa Ledoux
Léa Ledoux
MNMacha Nikolski
Macha Nikolski
Mass spectrometry imaging (MSI) maps metabolites and lipids in tissue with spatial resolution, but molecular identity remains partly resolved: single ions match multiple candidate compounds, and most detected metabolites and lipids fall outside canonical biochemical pathways. We developed SpacePath, a computational framework that retains ion-to-compound ambiguity, scores canonical pathways across tissue locations, and groups assignments that were unmapped to pathways into de novo molecular families by chemical similarity. Pathway mappings covered on average only 1% of molecular assignments, whereas the combined SpacePath representation covered 24% of pooled assignments. Benchmarking on four public spatial lipidomics datasets (healthy mouse brain, cerebellum, a demyelination model, and human bladder cancer) recovered previously reported spatial patterns. In newly acquired glioblastoma xenograft datasets, SpacePath identified lipid programs specific to tumor and surrounding brain, and SpiderMass-MS/MS independently confirmed four tumor-associated features from a de novo family, refining the initial MS1 assignments. SpacePath extends the spatial interpretation of MSI data beyond canonical pathways while preserving annotation uncertainty.